196 related articles for article (PubMed ID: 17706952)
1. Infarct size limitation by adrenomedullin: protein kinase A but not PI3-kinase is linked to mitochondrial KCa channels.
Nishida H; Sato T; Miyazaki M; Nakaya H
Cardiovasc Res; 2008 Jan; 77(2):398-405. PubMed ID: 17706952
[TBL] [Abstract][Full Text] [Related]
2. 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (cilostazol), a phosphodiesterase type 3 inhibitor, reduces infarct size via activation of mitochondrial Ca2+-activated K+ channels in rabbit hearts.
Fukasawa M; Nishida H; Sato T; Miyazaki M; Nakaya H
J Pharmacol Exp Ther; 2008 Jul; 326(1):100-4. PubMed ID: 18381926
[TBL] [Abstract][Full Text] [Related]
3. Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection.
Wang X; Fisher PW; Xi L; Kukreja RC
J Mol Cell Cardiol; 2008 Jan; 44(1):105-13. PubMed ID: 18021798
[TBL] [Abstract][Full Text] [Related]
4. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha.
Gao Q; Zhang SZ; Cao CM; Bruce IC; Xia Q
Cytokine; 2005 Dec; 32(5):199-205. PubMed ID: 16260145
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Ca2+-activated K+ channels in cardiac myocytes: a mechanism of the cardioprotective effect and modulation by protein kinase A.
Sato T; Saito T; Saegusa N; Nakaya H
Circulation; 2005 Jan; 111(2):198-203. PubMed ID: 15623543
[TBL] [Abstract][Full Text] [Related]
6. Effects of sulfonylureas on mitochondrial ATP-sensitive K+ channels in cardiac myocytes: implications for sulfonylurea controversy.
Sato T; Nishida H; Miyazaki M; Nakaya H
Diabetes Metab Res Rev; 2006; 22(5):341-7. PubMed ID: 16444778
[TBL] [Abstract][Full Text] [Related]
7. Activation of mitochondrial large-conductance calcium-activated K+ channels via protein kinase A mediates desflurane-induced preconditioning.
Redel A; Lange M; Jazbutyte V; Lotz C; Smul TM; Roewer N; Kehl F
Anesth Analg; 2008 Feb; 106(2):384-91, table of contents. PubMed ID: 18227289
[TBL] [Abstract][Full Text] [Related]
8. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion.
Kobayashi H; Miura T; Ishida H; Miki T; Tanno M; Yano T; Sato T; Hotta H; Shimamoto K
Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):812-9. PubMed ID: 18346168
[TBL] [Abstract][Full Text] [Related]
9. New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: mitochondrial ion channels and cardioprotection.
Nishida H; Sato T; Ogura T; Nakaya H
J Pharmacol Sci; 2009 Mar; 109(3):341-7. PubMed ID: 19270424
[TBL] [Abstract][Full Text] [Related]
10. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.
Li H; Wang JK; Zeng YM; Yang CX; Chen HT; Wen XJ; Shui CL; Liang H
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
Burley DS; Baxter GF
Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
[TBL] [Abstract][Full Text] [Related]
12. Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection.
Sato T; Costa AD; Saito T; Ogura T; Ishida H; Garlid KD; Nakaya H
J Pharmacol Exp Ther; 2006 Jan; 316(1):182-8. PubMed ID: 16174795
[TBL] [Abstract][Full Text] [Related]
13. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
Hönisch A; Theuring N; Ebner B; Wagner C; Strasser RH; Weinbrenner C
Basic Res Cardiol; 2010 Mar; 105(2):155-67. PubMed ID: 19842009
[TBL] [Abstract][Full Text] [Related]
14. Dual signaling via protein kinase C and phosphatidylinositol 3'-kinase/Akt contributes to bradykinin B2 receptor-induced cardioprotection in guinea pig hearts.
Li Y; Sato T
J Mol Cell Cardiol; 2001 Nov; 33(11):2047-53. PubMed ID: 11708848
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone-induced myocardial protection against ischaemia-reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway.
Zhang XJ; Xiong ZB; Tang AL; Ma H; Ma YD; Wu JG; Dong YG
Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):156-61. PubMed ID: 19566839
[TBL] [Abstract][Full Text] [Related]
16. Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits.
Salloum FN; Ockaili RA; Wittkamp M; Marwaha VR; Kukreja RC
J Mol Cell Cardiol; 2006 Mar; 40(3):405-11. PubMed ID: 16480739
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin limits reperfusion injury in experimental myocardial infarction.
Hamid SA; Baxter GF
Basic Res Cardiol; 2005 Sep; 100(5):387-96. PubMed ID: 16010601
[TBL] [Abstract][Full Text] [Related]
18. Testosterone induces cytoprotection by activating ATP-sensitive K+ channels in the cardiac mitochondrial inner membrane.
Er F; Michels G; Gassanov N; Rivero F; Hoppe UC
Circulation; 2004 Nov; 110(19):3100-7. PubMed ID: 15520315
[TBL] [Abstract][Full Text] [Related]
19. [Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart].
Ogita H; Node K; Asanuma H; Sanada S; Takashima S; Asakura M; Kitakaze M; Hori M
J Cardiol; 2002 Jan; 39(1):55-6. PubMed ID: 11828800
[TBL] [Abstract][Full Text] [Related]
20. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
